A New Clinical Trial for Participants with Idiopathic Pulmonary Fibrosis (IPF)

Are You Eligible? Answer the Following Questions:

First Name:

Last Name:

Address:

Email:

Phone:

Select Your Nearest Trial Location From the Dropdown List

Yes No

Yes No

Are you currently on any approved or investigational IPF therapies or oral corticosteroids?

Yes NoIf yes, please list these therapies.

Have you been diagnosed with significant coronary artery disease (i.e., myocardial infarction or unstable angina)?

Yes No If yes, please share the date of diagnosis.

Yes No If yes, please share the date of diagnosis.

Yes No

Do you have a known history of hypersensitivity or intolerance to oral tazarotene?

Yes No Not Sure

If eligible, are you willing and able to participate in this 18-week clinical trial?

Yes No If yes, would you like to be contacted by a study site? Yes No

For spam protection, please type "gri"

Once you have answered all the questions, please click to submit your answers